Vascular responses to IGF-I and insulin are impaired in aortae of hypertensive rats

J Hypertens. 2005 Feb;23(2):351-8. doi: 10.1097/00004872-200502000-00017.

Abstract

Objective: Insulin-like growth factor-I (IGF-I) and insulin are important vasoactive peptides but little is known about their effects in hypertension.

Design: We compared the responses of stroke-prone spontaneously hypertensive rats (SHRSP) and Wistar-Kyoto (WKY) rat aortae to IGF-I and insulin.

Methods: Aortae were removed from WKY and SHRSP, cut into 2-3 mm rings, and contractile responses to phenylephrine and endothelin-1 studied in organ chambers in the presence of vehicle, IGF-I (0.1 micromol/l) or insulin (0.1 micromol/l). In addition, the effects of nitric oxide synthase (NOS) inhibition, phosphatidylinositol 3-kinase (PI3-kinase) inhibition and superoxide scavenging on these responses were investigated.

Results: Incubation with IGF-I and insulin caused attenuation of phenylephrine-induced and endothelin-1-induced vasoconstriction in arteries from normotensive but not hypertensive animals. In the arteries from WKY rats, co-incubation with either wortmannin or LY294002, inhibitors of PI3-kinase, attenuated the effect of IGF-I. The vasorelaxant effect of IGF-I was also abolished by removal of the endothelium or addition of the NOS inhibitor, N-nitro-L-arginine methyl ester (L-NAME). Co-incubation with tiron, a superoxide scavenger, suggested that the attenuation of IGF-I vasodilation in SHRSP arteries was not due to excess superoxide production.

Conclusion: In WKY, IGF-I/insulin attenuate phenylephrine-mediated constrictions via PI3-kinase/nitric oxide pathways. In contrast, in SHRSP these pathways are dysfunctional and IGF-I has little effect on vascular responses.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstadienes / pharmacology
  • Animals
  • Aorta, Thoracic / drug effects*
  • Chromones / pharmacology
  • Endothelin-1 / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Female
  • Hypertension / physiopathology*
  • Insulin / pharmacology*
  • Insulin-Like Growth Factor I / pharmacology*
  • Morpholines / pharmacology
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Phenylephrine / pharmacology
  • Phosphoinositide-3 Kinase Inhibitors
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Species Specificity
  • Vasoconstriction / drug effects*
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects*
  • Wortmannin

Substances

  • Androstadienes
  • Chromones
  • Endothelin-1
  • Enzyme Inhibitors
  • Insulin
  • Morpholines
  • Phosphoinositide-3 Kinase Inhibitors
  • Vasoconstrictor Agents
  • Phenylephrine
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Insulin-Like Growth Factor I
  • Nitric Oxide Synthase
  • NG-Nitroarginine Methyl Ester
  • Wortmannin